Shanghai DeltaHealth Hospital
Shanghai DeltaHealth Hospital: An International High-End General Hospital Specializing in Cardiovascular Care
I. Hospital Overview
Shanghai DeltaHealth Hospital is a tertiary general hospital jointly established by United Family Healthcare, a globally renowned medical group, and Hong Kong Delta Healthcare Group. It commenced operations in 2018. With cardiovascular disease diagnosis and treatment as its core specialty, the hospital also covers multiple disciplines, including general medicine, oncology, surgery, and obstetrics and gynecology. It is Shanghai's first foreign-invested general hospital accredited by the Joint Commission International (JCI) and serves as a benchmark institution for precision cardiovascular care in the Yangtze River Delta region.
Located at 100 Century Avenue in Shanghai's Pudong New Area, adjacent to the Shanghai World Financial Center, the hospital spans approximately 80,000 square meters. It offers over 300 beds and treats more than 100,000 patients annually, with 35% being international patients and high-net-worth individuals from mainland China. Adhering to a “patient-centered” service philosophy, the hospital integrates international medical standards with the needs of Chinese patients. It has established a comprehensive health management system covering the entire cycle of “prevention-diagnosis-treatment-rehabilitation,” committed to providing “safe, precise, and humanized” medical services.
II. Technical Advantages: Dual Engines of “Precision Interventional and Minimally Invasive Surgery” in the Cardiovascular Field
Shanghai DeltaHealth Hospital's core competitiveness stems from its technological innovation and multidisciplinary collaboration in cardiovascular disease treatment. It holds a leading position nationally in managing complex coronary artery disease, structural heart disease, arrhythmias, and end-stage heart conditions.
• Interventional Treatment for Complex Coronary Artery Disease:
The hospital's Cardiology Department features a world-class Philips Ingenia 3.0T MRI-DSA hybrid operating room, enabling real-time fusion of “interventional + imaging” data. This facilitates high-complexity procedures such as chronic total occlusion (CTO), left main bifurcation lesions, and calcified lesions, achieving a success rate exceeding 98% with a complication rate below 1% (Source: 2024 Annual Report on Interventional Cardiovascular Therapy in China).
• Minimally Invasive Treatment for Structural Heart Disease:
Our cardiac and great vessel surgery team specializes in minimally invasive techniques like Transcatheter Aortic Valve Implantation (TAVI) and MitraClip, enabling valve repair or replacement without open-chest surgery. Patients typically discharge within 3 days post-procedure, with 1-year survival rates exceeding 95%.
• Precision Ablation for Arrhythmias:
Utilizing Germany's CARTO 3 three-dimensional mapping system and cryoballoon ablation technology, we achieve immediate procedural success rates exceeding 95% for complex arrhythmias like atrial fibrillation and ventricular tachycardia, with recurrence rates reduced by 30% compared to traditional approaches.
• End-Stage Heart Disease Solutions:
In collaboration with the International Organ Transplant Center, we provide pre-transplant evaluations, ECMO (extracorporeal membrane oxygenation) support therapy, and long-term postoperative management. Heart transplant patients achieve a 1-year survival rate of 90% (compared to the international average of approximately 85%).
III. Leading Specialties: Holistic Development Centered on Cardiovascular Medicine
With cardiovascular medicine as its flagship specialty, the hospital integrates other disciplines to form a “specialized excellence, comprehensive care” diagnostic and treatment network. Key focus areas include the following leading specialty clusters:
1. Cardiovascular Medicine:
Focusing on common and complex conditions such as coronary heart disease, hypertension, and heart failure, the department operates three specialized centers: the Chest Pain Center, Atrial Fibrillation Center, and Heart Failure Center. It performs over 3,000 interventional procedures annually, ranking first among foreign-invested hospitals in Shanghai for chronic total occlusion (CTO) procedures.
2. Cardiac and Great Vessel Surgery:
Led by an American College of Cardiology (ACC) Fellow, this department performs complex procedures including minimally invasive cardiac surgery (e.g., thoracoscopic valve repair) and major vessel replacement (e.g., aortic dissection repair). These techniques reduce surgical trauma by 60% compared to traditional open-heart approaches.
3. Comprehensive Oncology Department:
For lung cancer, breast cancer, and gastrointestinal tumors, we provide a multidisciplinary team (MDT) model integrating “surgery + radiotherapy + targeted therapy + immunotherapy.” With planned proton therapy equipment and precision genetic testing, we extend median survival by 30% for advanced cancer patients.
4. Internal Medicine (General & Specialty):
Features subspecialties including endocrinology, respiratory medicine, and gastroenterology. Expertise includes comprehensive chronic disease management such as diabetes care (continuous glucose monitoring + intensive insulin pump therapy) and chronic obstructive pulmonary disease (COPD) treatment following GINA guidelines.
5. Surgery (Minimally Invasive & Plastic):
Performs minimally invasive procedures, including laparoscopic gastrectomy/colorectal cancer resection and thyroidectomy. Also offers cosmetic services like facial rejuvenation and breast augmentation, with regular consultations by plastic surgeons from South Korea and Japan.
IV. Core Departments & Collaborative Service System
The hospital has established an integrated service network spanning “examination-diagnosis-treatment-rehabilitation.” Core departments include:
• Medical Imaging Center: Equipped with GE Revolution CT (256-slice), Siemens Prisma 3.0T MRI, and Philips EPIQ 7C cardiac ultrasound, supporting precise imaging assessments such as coronary CTA and cardiac magnetic resonance imaging (CMR).
• Pathology Diagnostic Center: Collaborates with Johns Hopkins Hospital's Pathology Department for remote consultations, reducing routine pathology report turnaround to 2 hours with 99% accuracy for complex cases.
• Rehabilitation Medicine Center: Provides exercise rehabilitation and cardiopulmonary training for post-surgical patients (e.g., cardiac and orthopedic surgeries). Equipped with Swiss Hocoma rehabilitation robots, it reduces patient hospital stays by 30%.
• International Medical Department: Features a dedicated ward area (including private rooms and suites) staffed by bilingual nursing teams. Services include cross-border medical document translation and overseas medication procurement.
V. Medical Equipment: World-Class Devices Empowering Precision Diagnosis and Treatment
The hospital's equipment configuration meets international top-tier standards, with all core devices certified by both CE and NMPA. These include:
• Philips Ingenia 3.0T MRI-DSA Hybrid Operating Room: A globally leading integrated “MRI + Angiography” system enabling real-time MRI scanning during interventional procedures for precise lesion assessment.
• Abbott CardioMEMS HF System: An implantable heart failure monitoring device that continuously tracks pulmonary capillary wedge pressure (PCWP), reducing readmission rates for heart failure patients by 40%.
• Edwards SAPIEN 3 Transcatheter Aortic Valve System: The world's most widely used interventional valve, supporting trans-femoral/trans-apical approaches for patients with severe aortic stenosis.
• Da Vinci Xi Surgical Robot: Used for minimally invasive procedures in cardiac and urological surgery. Its robotic arms rotate 540 degrees, requiring only 1-2 cm incisions and reducing blood loss by 80%.
VI. International Patient Services: Seamless Global Healthcare Experience
As a JCI-accredited hospital, Shanghai DeltaHealth Hospital provides international patients with comprehensive, multilingual, customized services covering the entire treatment journey:
• Language Support: Staffed with native-speaking nurses and interpreters from the UK, US, Australia, Canada, etc., 30% of our physician team holds international medical credentials (e.g., USMLE certification, European Accreditation of Cardiology Clinicians), enabling direct communication in English, Spanish, and other languages.
• Direct Billing with International Insurers: Partnering with over 50 global insurers, including UnitedHealthcare (US), Bupa (UK), MSH (Japan), and AXA (France), we facilitate direct payment for outpatient and inpatient services—no upfront costs required.
• Streamlined Care Access: Dedicated appointment channels for international patients (website/WeChat official account/customer service hotline) with airport/high-speed rail station pickup (Pudong/Hongqiao hubs only). Comprehensive patient navigation assistance covering registration, testing, and medication pickup.
• Telemedicine: Established remote consultation systems with world-leading institutions, including Mayo Clinic (USA), Cleveland Clinic (USA), and The Royal Brigham and Women's Hospital (UK), enabling patients to obtain second opinions from international specialists in real time.
• Postoperative Care: Multilingual recovery guides (English, Japanese, Korean) are provided for international patients, with regular video follow-ups to monitor progress. Foreign patients may schedule dedicated health concierges to assist with follow-up appointments, medication procurement, and daily life translation.
VII. International Patient Testimonials: “Global Reputation for Expertise and Warmth”
• Robert (65, USA, recurrent coronary artery disease post-stenting): "I had two stenting procedures in Boston, but still experienced chest pain. Dr. Li's cardiac intervention team precisely located my vascular calcification using OCT (optical coherence tomography). The complex lesion was successfully treated in just one hour. Now I hike regularly—even my family doctor marvels at my recovery speed!"
• Japanese Patient Yuki (42, atrial fibrillation): “I worried about language barriers, but my attending physician, Dr. Li, explained the procedure in fluent Japanese. After cryoballoon ablation, I returned to work in Tokyo the next day. No AF episodes in three months—it's incredible!”
• Australian patient Michael (58, aortic dissection): “The emergency team at DeDa completed the contrast CT scan and preoperative preparations within 20 minutes. The cardiac surgeon replaced my aortic valve using minimally invasive techniques. Postoperatively, I received specialized respiratory therapy at the rehabilitation center. My cardiac function has now returned to normal. Thank you to DeDa for their professionalism and meticulous care!”
VIII. Contact Information, Address, and Transportation Routes
Hospital Address: 100 Century Avenue, Pudong New Area, Shanghai (West of Shanghai World Financial Center, near Yincheng Middle Road)
Contact: 021-5033 9999 (Main Switchboard); 400-821-5888 (International Patient Hotline)
Transportation Routes:
• Subway: Take Line 2 to “Lujiazui Station” (Exit 6), 8-minute walk; or Line 14 to “Lujiazui Station” (Exit 5), 5-minute walk.
• Bus: Routes 81, 82, 85, 795 to “Lujiazui Ring Road-Mingshang Road Station”, 3-minute walk.
• Driving: The hospital offers underground parking (Levels B2-B4). Present your appointment confirmation for 3 hours of complimentary parking (additional hours charged at ¥15/hour).
Conclusion
Shanghai DeltaHealth Hospital centers its mission on “Precision Diagnosis and Treatment of Cardiovascular Diseases,” supported by international medical standards. We continuously advance multidisciplinary innovation and enhance patient services. Whether addressing complex cardiovascular surgeries, chronic disease management, or the personalized needs of international patients, the hospital remains committed to its mission of “enabling global patients to access superior medical care.” We strive to become a benchmark for high-end medical services in the Yangtze River Delta region and across China.
Document dated 2025-09-15 11:01 Modify